Working closely with the President’s Malaria Initiative (PMI) in both Washington and PMI- focus countries, the US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program aims to ensure the availability of quality pharmaceutical products and effective pharmaceutical services in support of PMI objectives. To this end, and based … Read more
Welcome to the 2016 Edition of the Malaria Newsletter! We are glad you are reading. In this edition, you will find information on the tremendous work that is being done by the National Malaria Control Programme (NMCP) and its partners to reduce malaria-related morbidity and mortality in South Sudan. This April 25, 2016, South Sudan … Read more
According to the World Health Organization (WHO), the number of malaria deaths malaria mortality rates fell by 48% globally, and the number of malaria cases by 18% between 2000 and 2015. During this period, it is estimated that 6.2 million fewer malaria deaths occurred globally, primarily as a result of the scale-up of interventions. However, … Read more
O presente relatório objetiva descrever as ações desenvolvidas no município de Itaituba, sudoeste do estado do Pará, que buscam promover o acesso ao diagnóstico e ao uso de medicamentos em áreas de garimpo. Disclaimer: These documents have been finalized in collaboration with country partners and have not been reviewed by SIAPS Program editorial staff
This bulletin is developed through a collaborative effort between the National Malaria Control Programs of the Region of the Americas, PAHO/WHO and SIAPS/USAID to facilitate sharing of information between countries in the Americas. The objectives of the bulletin are to increase awareness of stocks of antimalarial medicine, generate stock out alerts and promote exchanges and … Read more
En 2001 el Perú fue el primer país en las Américas que adoptó la Terapia de Combinación con Artemisininas (TCA) como tratamiento de primera línea para malaria no complicada por P. falciparum, estableciendo el uso de dos esquemas: Artesunato + Sulfadoxina/pirimetamina (para la Costa Norte) y Artesunato + Mefloquina (para la Amazonía). En los últimos … Read more
SIAPS Program provides support to the US President’s Malaria Initiative (PMI) country programs to address challenges to ensuring an uninterrupted supply of high-quality medicines and commodities as well as their appropriate use. SIAPS Program collaborates with PMI and field programs to strengthen pharmaceutical management systems for the benefit of national malaria control programs (NMCP). In … Read more
According to the World Health Organization (WHO), 1 malaria mortality rates fell by 47% globally, and by 54% in Africa between 2000 and 2013. During this period, an estimated 4.3 million malaria deaths were averted globally, primarily as a result of the scale-up of interventions. However, much remains to be done. Although 55 countries are … Read more
SIAPS conducted a review of regulatory and quality assurance efforts in the GMS with the following objectives— To inform PMI of past and current initiatives to improve the capacity of the region to combat counterfeit, substandard, and banned antimalarial medicines To understand the current barriers to effective medicine quality control for malaria To recommend specific … Read more
La présente étude vise à examiner la faisabilité d’une introduction des tests de diagnostic rapide (TDR) et combinaisons thérapeutiques à base d’artémisinine (CTA) subventionnés pour la prise en charge du paludisme dans les pharmacies du secteur privé au Mali, et déterminer quels éléments doivent être pris en compte afin de garantir que cette introduction s’effectue … Read more
